Ono Pharmaceutical Dividende
Dividende contrôle des critères 6/6
Ono Pharmaceutical is a dividend paying company with a current yield of 4.09% that is well covered by earnings. Next payment date is on 2nd December, 2024 with an ex-dividend date of 27th September, 2024.
Informations clés
4.1%
Rendement du dividende
2.5%
Rendement des rachats
| Rendement total pour l'actionnaire | 6.6% |
| Rendement futur des dividendes | 4.0% |
| Croissance des dividendes | 7.6% |
| Prochaine date de paiement du dividende | 02 Dec 24 |
| Date ex-dividende | 27 Sep 24 |
| Dividende par action | JP¥80.000 |
| Ratio de distribution | 20% |
Mises à jour récentes des dividendes
Recent updates
Ono Pharmaceutical Co., Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Nov 03
We Think Ono Pharmaceutical (TSE:4528) Can Stay On Top Of Its Debt
Aug 25Ono Pharmaceutical Co., Ltd. (TSE:4528) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Aug 04There's No Escaping Ono Pharmaceutical Co., Ltd.'s (TSE:4528) Muted Earnings
Jun 24Ono Pharmaceutical (TSE:4528) Has Announced A Dividend Of ¥40.00
Mar 04Is There An Opportunity With Ono Pharmaceutical Co., Ltd.'s (TSE:4528) 42% Undervaluation?
Feb 27Stabilité et croissance des paiements
Récupération des données sur les dividendes
Dividende stable: 4528's dividends per share have been stable in the past 10 years.
Dividende croissant: 4528's dividend payments have increased over the past 10 years.
Rendement des dividendes par rapport au marché
| Ono Pharmaceutical Rendement des dividendes par rapport au marché |
|---|
| Segment | Rendement du dividende |
|---|---|
| Entreprise (4528) | 4.1% |
| 25% du marché (JP) | 1.8% |
| 25% du marché (JP) | 3.8% |
| Moyenne du secteur (Pharmaceuticals) | 2.2% |
| Analyste prévisionnel (4528) (jusqu'à 3 ans) | 4.0% |
Dividende notable: 4528's dividend (4.09%) is higher than the bottom 25% of dividend payers in the JP market (1.83%).
Dividende élevé: 4528's dividend (4.09%) is in the top 25% of dividend payers in the JP market (3.82%)
Bénéfice distribué aux actionnaires
Couverture des revenus: With its low payout ratio (19.8%), 4528's dividend payments are well covered by earnings.
Paiement en espèces aux actionnaires
Couverture des flux de trésorerie: With its reasonably low cash payout ratio (40.9%), 4528's dividend payments are well covered by cash flows.